Rolf Barth to Immunoconjugates
This is a "connection" page, showing publications Rolf Barth has written about Immunoconjugates.
Connection Strength
0.834
-
Safety of belatacept bridging immunosuppression in hepatitis C-positive liver transplant recipients with renal dysfunction. Transplantation. 2014 Jan 27; 97(2):133-7.
Score: 0.430
-
Transplantation: The promise of co-stimulatory blockade in transplantation. Nat Rev Nephrol. 2013 Apr; 9(4):189-90.
Score: 0.404